![John Kirby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Kirby
Directeur Financier/CFO chez
VERRICA PHARMACEUTICALS INC.
Fortune : 109 221 $ au 31/05/2026
Profil
John J.
Kirby is currently a Trustee at Delaware Museum of Natural History, Inc. since 2018 and Chief Financial Officer at Verrica Pharmaceuticals, Inc. starting in 2024.
Former positions include Regional Audit Director at AstraZeneca Pharmaceuticals LP from 2010 to 2012, Chief Accounting Officer & Vice President at Shire ViroPharma, Inc. from 2012 to 2014, Assistant Controller at Endo Pharmaceuticals, Inc. from 2014 to 2015, Chief Financial Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2019 to 2022, and Chief Financial Officer at Aceragen, Inc. from 2022 to 2023.
Education includes undergraduate studies at Villanova University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2026 | 18 962 ( 0,11% ) | 109 221 $ | 31/05/2026 |
Postes actifs de John Kirby
| Sociétés | Poste | Début |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Directeur Financier/CFO | 05/11/2024 |
Delaware Museum of Natural History, Inc.
 Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Operates a museum | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de John Kirby
| Sociétés | Poste | Fin |
|---|---|---|
| ACERAGEN, INC. | Directeur Financier/CFO | 28/04/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Directeur Financier/CFO | 01/09/2022 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Comptroller/Controller/Auditor | 01/10/2015 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Comptroller/Controller/Auditor | 01/07/2014 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Comptroller/Controller/Auditor | 01/08/2012 |
Formation de John Kirby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Delaware Museum of Natural History, Inc.
Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Operates a museum | Consumer Services |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
